Hospitals and community-based residential facilities (CBRFs) are the only two providers in Wisconsin for which the TB skin test is specified in the requirements. For all other types of licensed providers that require screening for infectious diseases (nursing homes, facilities for the developmentally disabled, etc.), the TB skin test is not specified. Thus, all other providers may also choose to screen for tuberculosis infection using QFT-G in place of the TB skin test without any special variance or waiver.
QuantiFERON®-TB Gold test (QFT-G), a whole-blood test for use in detecting Mycobacterium tuberculosis infection, received U.S. Food and Drug Administration (FDA) approval in 2005.
QFT-G may be used in ALL occupational settings in place of a skin test.
The Tuberculosis Program can provide additional information about the use of QuantiFERON®-TB Gold in Wisconsin.
Facilities in/near Wisconsin offering QuantiFERON®-TB Gold
Facilities listed are provided for convenience purposes only. Their use does not imply endorsement by the Wisconsin Department of Health Services. Call the individual facility for details.
ACL Laboratories (PDF, 96 KB)
Fond du Lac, Wisconsin
SMDC Clinical Laboratory
St. Elizabeth Hospital Laboratory
St. Vincent Hospital
Green Bay, Wisconsin
West Bend Clinic
West Bend, Wisconsin
262-334-3451 ext. 2304
262-334-3451 ext. 2365
For more information or questions, contact the Respiratory Diseases and International Health Unit or your Wisconsin Local Health Department.